{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:34:20Z","timestamp":1765960460439,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.jaad.2004.03.020","type":"journal-article","created":{"date-parts":[[2004,7,22]],"date-time":"2004-07-22T15:46:18Z","timestamp":1090511178000},"page":"124-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"S","title":["Self-resolution of Epstein-Barr virus\u2013associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate"],"prefix":"10.1016","volume":"51","author":[{"given":"Mark A","family":"Waldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey P","family":"Callen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2004.03.020_BIB1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJM200101113440207","article-title":"Brain tumors","volume":"344","author":"DeAngelis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.03.020_BIB2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.1365-2133.1996.d01-946.x","article-title":"Reversible cutaneous lymphoma occurring during methotrexate therapy","volume":"135","author":"Viraben","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199305063281806","article-title":"Brief Report: Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis","volume":"328","author":"Kamel","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.03.020_BIB4","first-page":"47","article-title":"Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjogren's syndrome: Case series","volume":"28","author":"Daswon","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0025-6196(11)63231-X","article-title":"Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients with methotrexate","volume":"76","author":"Tournadre","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2004.03.020_BIB6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0046-8177(94)90295-X","article-title":"Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: Frequency of Epstein-Barr virus and other features associated with immunosuppression","volume":"25","author":"Kamel","year":"1994","journal-title":"Human Pathol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1600-0560.1999.tb01837.x","article-title":"Epstein Barr virus-associated lymphoproliferative-disorders primarily involving the skin","volume":"26","author":"Chai","year":"1999","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB8","first-page":"9","article-title":"Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark","volume":"6","author":"Chow","year":"1995","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jaad.2004.03.020_BIB9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1054\/bjoc.2001.1699","article-title":"Risk on cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study","volume":"85","author":"Stockton","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2004.03.020_BIB10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2004.03.020_BIB11","first-page":"1300","article-title":"Elevated cancer incidence in patients with dermatomyositis: A population based study","volume":"22","author":"Airio","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11926-002-0087-9","article-title":"Malignancy in patients with inflammatory myopathy","volume":"4","author":"Buchbinder","year":"2002","journal-title":"Curr Rheum Reports"},{"key":"10.1016\/j.jaad.2004.03.020_BIB13","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.1996.14.6.1943","article-title":"Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases","volume":"14","author":"Salloum","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB14","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy: A population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2004.03.020_BIB15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0002-9343(99)80160-0","article-title":"hematologic malignancies and the use of methotrexate in rheumatoid arthritis: A retrospective study","volume":"99","author":"Moder","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2004.03.020_BIB16","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.1780290702","article-title":"The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis","volume":"29","author":"Kremer","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2004.03.020_BIB17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0002-9343(85)90244-X","article-title":"Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens","volume":"78","author":"Hazelman","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2004.03.020_BIB18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0002-9343(85)90312-2","article-title":"Low-dose methotrexate treatment of rheumatoid arthritis: long term observation","volume":"79","author":"Weinstein","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2004.03.020_BIB19","first-page":"1741","article-title":"Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate","volume":"18","author":"Ellman","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB20","first-page":"1095","article-title":"Non-Hodgkin's lymphoma in patients with rheumatoid arthritis treated with low dose methotrexate","volume":"23","author":"Usman","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB21","first-page":"500","article-title":"Remission of lymphoma after drug withdrawal in rheumatoid arthritis","volume":"177","author":"Lim","year":"2002","journal-title":"MJA"},{"key":"10.1016\/j.jaad.2004.03.020_BIB22","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V99.11.3909","article-title":"Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France","volume":"99","author":"Mariette","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2004.03.020_BIB23","first-page":"567","article-title":"Spontaneous remission of low-grade B-cell non-Hodgkin's lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literature","volume":"118","author":"Baird","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/art.1780390223","article-title":"Methotrexate-associated lymphoma in patients with rheumatoid arthritis: report of two cases","volume":"39","author":"Bachman","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2004.03.020_BIB25","first-page":"521","article-title":"Pseudolymphome cutane au cours du traitement d'une poyarthrite rhymatoide par le methotrexate a faibles doses","volume":"122","author":"Delaporte","year":"1995","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB26","first-page":"S204","article-title":"Lymphomatous changes during methotrexate therapy","volume":"38","author":"Davies","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2004.03.020_BIB27","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0049-0172(97)80023-6","article-title":"Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment","volume":"26","author":"Georgescu","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2004.03.020_BIB28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00124743-199604000-00002","article-title":"Lymphoma and leukemia in rheumatoid arthritis: Are they associated with azathiaprine, cyclophosphamide, or methotrexate? A matched case-control study in the Arthritis, Rheumatism and Aging Medical Information System (ARAMIS) population","volume":"2","author":"Williams","year":"1996","journal-title":"J Clin Rheum"},{"key":"10.1016\/j.jaad.2004.03.020_BIB29","first-page":"1172","article-title":"Complications of immunosuppression associated with weekly low dose methotrexate","volume":"18","author":"Shiroky","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study","volume":"326","author":"Sigurgeirsson","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.03.020_BIB31","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archderm.1990.01670290077012","article-title":"Prognostic factors and predictive signs of malignancy in adult dermatomyositis","volume":"126","author":"Basset-Seguin","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB32","first-page":"1855","article-title":"The overall and temporal association of cancer with polymyositis and dermatomyositis","volume":"21","author":"Zantos","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(99)05157-0","article-title":"Dermatomyositis","volume":"355","author":"Callen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2004.03.020_BIB34","first-page":"2230","article-title":"Polymyositis and dermatomyositis: Short term and longterm outcome, and predictive factors of prognosis","volume":"28","author":"Marie","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB35","first-page":"1174","article-title":"Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection","volume":"22","author":"Liote","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB36","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/ard.54.7.607-b","article-title":"Early development of Hodgkin's lymphoma in association with the use of methotrexate for the treatment of dermatomyositis","volume":"54","author":"Bittar","year":"1995","journal-title":"Ann Rheum Disease"},{"key":"10.1016\/j.jaad.2004.03.020_BIB37","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archderm.1997.03890430083011","article-title":"Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis","volume":"133","author":"Paul","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB38","first-page":"1462","article-title":"Association of methotrexate, rheumatoid arthritis and lymphoma: Report of 2 cases and literature review","volume":"19","author":"Kingsmore","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB39","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/1529-0131(199908)42:8<1773::AID-ANR29>3.0.CO;2-R","article-title":"Hodgkin's disease and B cell lymphoproliferation in rheumatoid arthritis patients treated with methotrexate: A kinetic study of lymph node changes","volume":"42","author":"Chevrel","year":"1999","journal-title":"Arthritis and Rheum"},{"key":"10.1016\/j.jaad.2004.03.020_BIB40","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00124743-199810000-00006","article-title":"Methotrexate and lymphoma: A presentation of four cases and review of the literature","volume":"4","author":"Kleiman","year":"1998","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB41","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/art.1780380624","article-title":"Epstein-Barr virus-associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A","volume":"38","author":"Ferracioli","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2004.03.020_BIB42","first-page":"806","article-title":"Malignancy in patient with rheumatoid arthritis treated with methotrexate","volume":"24","author":"Sukenik","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF02982134","article-title":"Epstein-Barr virus-associated lymphoma with concurrent p53 protein expression in a rheumatoid arthritis patient treated with methotrexate","volume":"75","author":"Hirose","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jaad.2004.03.020_BIB44","first-page":"294","article-title":"Hodgkin's disease following methotrexate therapy for rheumatoid arthritis","volume":"115","author":"Jardine","year":"2002","journal-title":"NZ Med J"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204008126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204008126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:34:04Z","timestamp":1759268044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962204008126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0190962204008126"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2004.03.020","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-resolution of Epstein-Barr virus\u2013associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2004.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}